FAKTOR OPTIONSSCHEIN - INCYTE CO. | Real-time BOERSE MUENCHEN 12:32:29 04/07/2024 pm IST | ||
| 5.198 EUR | 0.00% |
|
| Current month | -10.08% | ||
| 1 month | -4.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
INCYTE CORPORATION
Latest news about INCYTE CORPORATION
| Date | Price | Change |
|---|---|---|
| 04/24/04 | 5.198 | 0.00% |
| 03/24/03 | 5.198 | -5.88% |
| 02/24/02 | 5.523 | -5.05% |
| 01/24/01 | 5.817 | +0.62% |
| 28/24/28 | 5.781 | -2.45% |
Real-time BOERSE MUENCHEN
Last update July 04, 2024 at 12:32 pm IST
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | INCYTE CORPORATION |
| Issuer | Goldman Sachs |
| WKN | GX55AJ |
| ISIN | DE000GX55AJ9 |
| Date issued | 06/12/2021 |
| Strike | 29.51 $ |
| Maturity | Unlimited |
| Parity | 5.04 : 1 |
| Emission price | 9.94 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.28 € |
|---|---|
| Lowest since issue | 4.173 € |
| Spread | 0.02 € |
| Spread % | 0.38% |
Company Profile
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows:
- product sales (85.6%);
- royalties (14.2%);
- income from research and cooperation agreements (0.2%).
Sector
-
Consensus: Incyte Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
57.66
USD
Average target price
72.62
USD
Spread / Average Target
+25.94%
- Stock Market
- Certificates
- Certificat
